LOS ANGELES--(BUSINESS WIRE)--ImmunoCellular Therapeutics, Ltd. (OTCBB:IMUC) (“IMUC”) announced today that it will be holding an investor telephone conference call to discuss its new agreement to acquire a monoclonal antibody technology that was reported in a press release by IMUC earlier today and to update investors on IMUC’s other activities. The conference call will be held at 7:30 a.m. PST on Thursday, November 29, 2007. The call-in number for U.S. and Canadian investors will be 888-677-5725, and for other international investors, the call-in number will be 210-839-8725. The passcode for both numbers will be IMUC.
